CHROMA — Call Transcript 2025

Oct 30, 2025

==> picture [141 x 48] intentionally omitted <==

==> picture [323 x 112] intentionally omitted <==

2025.3Q Earnings Conference Call

Paul Ying, CFO

30[th] October, 2025

1

Disclaimer

==> picture [141 x 48] intentionally omitted <==

This presentation contains some forward-looking statements that are subject to substantial risks and uncertainties. Typically, these statements contain words such as “anticipate”, “believe”, “could”, “estimate”, “expect”, “intend”, “plan”, “forecast”, “project”, “predict”, “potential”, “continue”, “may”, “should”, “will”, and “would” or similar words. You should consider these forward-looking statements carefully because such statements are only our expectations or projections about future events, and actual results may differ materially from those expressed or implied by such statements. The forward-looking statements in this presentation include, but are not limited to, growth rates for various markets estimated by third party sources, future products and technology development, widespread market acceptance of the hosted delivery model, future revenue growth and profitability. You should be cautioned that the forward-looking statements are no guarantee of our future performance. The forward-looking statements contained in this presentation are made only as of the date of this presentation and we undertake no obligation to update the forward-looking statements to reflect subsequent events or circumstances, except as required by law.

This presentation and the information contained herein are the property of Chroma Ate Inc.

==> picture [917 x 37] intentionally omitted <==

2

Agenda

==> picture [141 x 48] intentionally omitted <==

==> picture [720 x 456] intentionally omitted <==

----- Start of picture text -----

•
Financial Review
•
Operation Highlights
•
Q&A
----- End of picture text -----

3

==> picture [15 x 439] intentionally omitted <==

FINANCIAL REVIEW

==> picture [671 x 11] intentionally omitted <==

==> picture [917 x 37] intentionally omitted <==

4

==> picture [141 x 48] intentionally omitted <==

Year 2025.3Q Condensed Consolidated Income Statement

==> picture [876 x 35] intentionally omitted <==

----- Start of picture text -----

Condensed Consolidated P&L 2025.3Q % 2025.2Q % QoQ % 2024.3Q % YoY %
(In Million NTD, except for EPS in NTD)
----- End of picture text -----

Condensed Consolidated P&L (In Million NTD, except for EPS in NTD)	2025.3Q %	2025.2Q % QoQ % 2024.3Q % YoY %
Net Sales	6,410 100%	6,455 100% (1%) 5,632 100% 14%
Consolidated Sales of Testing Equipment Business	6,155 96%	6,292 97% (2%) 5,170 92% 19%
Consolidated Sales of MAS	187 3%	94 2% 99% 384 7% (51%)
Others	68 1%	69 1% (1%) 78 1% (13%)
Cost of Goods Sold	(2,575) (40%)	(2,231) (35%) 15% (2,326) (41%) 11%
Gross Profit	3,835 60%	4,224 65% (9%) 3,306 59% 16%
Operating Expenses: General & Administration Research & Development	(1,336) (21%) (651) (10%)	(1,395) (22%) (4%) (1,290) (23%) 4% (632) (9%) 3% (508) (9%) 28%
Operating Income	1,848 29%	2,197 34% (16%) 1,508 27% 23%
Non-Operating Income (Expenses), net	3,626 56%	241 4% n/a 237 4% n/a
Income (Loss) Before Tax Income Tax	5,474 85% (360) (5%)	2,438 38% 125% 1,745 31% 214% (431) (7%) (16%) (295) (5%) 22%
Net Income	5,114 80%	2,007 31% 155% 1,450 26% 253%
Net Income (Losses) Attributable To:	5,066 79% 48 1%	1,953 30% 159% 1,426 25% 255% 54 1% (11%) 24 1% 100%
Shareholders of the Parent Noncontrolling Interests
	$ 5,114 80%	$ 2,007 31% 155% $ 1,450 26% 253%
EPS (Basic)	$ 11.99	$ 4.64 158% $ 3.39 254%
EPS (Diluted)	$ 11.92	$ 4.60 159% $ 3.36 255%

Gain from disposal of residential apartment held for sale (to employees) of NTD 3,185 million.

5

Year 2025.1~3Q Condensed Consolidated Income Statement

	Condensed Consolidated P&L (In Million NTD, except for EPS in NTD)	2025.1~3Q %
	Net Sales	19,730 100%
	Consolidated Sales of Testing Equipment Business	18,903 96%
	Consolidated Sales of MAS	629 3%
	Others	198 1%
	Cost of Goods Sold	(7,522) (38%)
	Gross Profit	12,208 62%
	Operating Expenses: General & Administration Research & Development	(4,110) (21%) (1,888) (10%)
	Operating Income	6,210 31%
	Non-Operating Income (Expenses), net	4,300 22%
	Income (Loss) Before Tax Income Tax	10,510 53% (1,233) (6%)
	Net Income	9,277 47%
	Net Income (Losses) Attributable To: Shareholders of the Parent Noncontrolling Interests	9,142 46% 135 1%
		$ 9,277 47%
	EPS (Basic)	$ 21.67
	EPS (Diluted)	$ 21.52

Balance Sheet Highlights & Financial Ratio

==> picture [141 x 48] intentionally omitted <==

Consolidated (In Million NTD)		2025. Sept	2024. Dec	+ / - %
Balance Sheet Highlights
Cash & Short Term Investments		7,171	5,040		42%
Inventory		6,982	5,827		20%
Short Term Debt		836	1,417	-	41%
Long Term Debt		3,168	2,108		50%
Shareholders Equity		30,059	25,450		18%
Total Assets		43,160	37,308		16%
Inventory Turnover (Day)		230	209
AR Turnover (Day)		85	87
AP Turnover (Day)		120	118
Net Debt to Equity (%)		Net Cash	Net Cash
ROE (%)		29%	22%
ROA (%)		20%	15%
Cash Position	2025.1~3Q	2024.1~3Q	YoY
EBITDA	11,155	5,378	107%
Cash Flow from Operation	2,864	2,951	(3%)
Free Cash Flow	5,055	1,903	166%

==> picture [9 x 9] intentionally omitted <==

All ROE + ROA has been annualized and without capital gain from disposal of residential held for sale.

Free Cash Flow = Net Cash Provided by Operating Activities + (Net Cash used by Investing Activities)

7

==> picture [15 x 439] intentionally omitted <==

==> picture [141 x 48] intentionally omitted <==

OPERATION

==> picture [671 x 11] intentionally omitted <==

HIGHLIGHT

==> picture [917 x 37] intentionally omitted <==

8

2025.3Q & 1~3Q Product Mix and Consolidated Sales Breakdown

==> picture [141 x 48] intentionally omitted <==

	(Unit: Million NTD)	2025.3Q % QoQ YoY 2025.1~3Q % YoY	2024 %
	Test Instruments & Automatic Testing System (ATS)	3,011 55% 12% 74% 7,913 49% 54%	6,825 44%
	Semiconductor / Photonics Test Solutions	2,092 38% (5%) 15% 6,896 43% 41%	6,974 45%
	Turnkey Solutions	55 1% (55%) (48%) 328 2% (39%)	685 4%
	Service & Others	334 6% 6% 3% 932 6% 4%	1,168 7%
	Total of Parent Company Sales	5,492 100% 3% 38% 16,069 100% 40%	15,652 100%
	+ Sales from Overseas Operations & Related Subsidiaries	663 (31%) (44%) 2,834 (12%)	4,767
	Chroma Consolidated Testing Equipment Business	6,155 96% (2%) 19% 18,903 96% 29%	20,419 95%
	MAS Other Subsidiaries	187 3% 99% (51%) 629 3% (5%) 68 1% (1%) (13%) 198 1% (18%)	872 4% 313 1%
	Consolidated Sales	6,410 100% (1%) 14% 19,730 100% 27%	21,604 97%

9

==> picture [141 x 48] intentionally omitted <==

==> picture [202 x 203] intentionally omitted <==

==> picture [585 x 195] intentionally omitted <==

Thank You

10 Copyright © 2023 Chroma ATE Inc. All rights reserved.